BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30243186)

  • 21. Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma.
    Watanabe S; Kuwabara Y; Suehiro S; Yamashita D; Tanaka M; Tanaka A; Ohue S; Araki H
    Eur J Clin Pharmacol; 2017 Mar; 73(3):357-363. PubMed ID: 27889835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
    Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
    J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of children with malignant brain tumors receiving valproate: a retrospective study.
    Felix FH; de Araujo OL; da Trindade KM; Trompieri NM; Fontenele JB
    Childs Nerv Syst; 2013 Feb; 29(2):195-7. PubMed ID: 23233213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients.
    Rigamonti A; Imbesi F; Silvani A; Gaviani P; Agostoni E; Porcu L; De Simone I; Torri V; Salmaggi A
    J Neurol Sci; 2018 Jul; 390():14-19. PubMed ID: 29801876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
    Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
    J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine versus valproic acid monotherapy for generalised epilepsy: A meta-analysis of comparative studies.
    Tang L; Ge L; Wu W; Yang X; Rui P; Wu Y; Yu W; Wang X
    Seizure; 2017 Oct; 51():95-101. PubMed ID: 28826049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid as the AED of choice for patients with glioblastoma? The jury is out.
    Wen PY; Schiff D
    Neurology; 2011 Sep; 77(12):1114-5. PubMed ID: 21880995
    [No Abstract]   [Full Text] [Related]  

  • 28. Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.
    Proske J; Walter L; Bumes E; Hutterer M; Vollmann-Zwerenz A; Eyüpoglu IY; Savaskan NE; Seliger C; Hau P; Uhl M
    Anticancer Res; 2016 Mar; 36(3):899-905. PubMed ID: 26976976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
    Lu VM; Alvi MA; McDonald KL; Daniels DJ
    J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
    Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
    J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin use and survival following glioblastoma multiforme.
    Gaist D; Hallas J; Friis S; Hansen S; Sørensen HT
    Cancer Epidemiol; 2014 Dec; 38(6):722-7. PubMed ID: 25455652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
    Zhao H; Wang S; Song C; Zha Y; Li L
    World J Surg Oncol; 2016 Oct; 14(1):261. PubMed ID: 27733166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
    Vaios EJ; Nahed BV; Muzikansky A; Fathi AT; Dietrich J
    J Neurosurg; 2017 Jul; 127(1):132-138. PubMed ID: 27739940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does valproic acid affect tumor growth and improve survival in glioblastomas?
    Rudà R; Pellerino A; Soffietti R
    CNS Oncol; 2016; 5(2):51-3. PubMed ID: 26985579
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of valproic acid on dementia onset in patients with bipolar disorder.
    Tsai PS; Liu IC; Chiu CH; Huang CJ; Wang MY
    J Affect Disord; 2016 Sep; 201():131-6. PubMed ID: 27208500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.
    Reddy JP; Dawood S; Mitchell M; Debeb BG; Bloom E; Gonzalez-Angulo AM; Sulman EP; Buchholz TA; Woodward WA
    Radiother Oncol; 2015 Nov; 117(2):308-14. PubMed ID: 26482599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of valproic acid on outcome of high-grade gliomas in children.
    Masoudi A; Elopre M; Amini E; Nagel ME; Ater JL; Gopalakrishnan V; Wolff JE
    Anticancer Res; 2008; 28(4C):2437-42. PubMed ID: 18751431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age alone is not a predictor for survival in glioblastoma.
    Gately L; Collins A; Murphy M; Dowling A
    J Neurooncol; 2016 Sep; 129(3):479-485. PubMed ID: 27406585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.